US FDA Unveils AI Tool to Enhance Efficiency – Tech in Asia

The U.S. Food and Drug Administration (FDA) has introduced a new artificial intelligence (AI) tool designed to enhance its operational efficiency. This AI initiative aims to streamline various regulatory processes, making it easier to manage the influx of applications and data. By leveraging advanced algorithms, the tool will assist in analyzing information more rapidly and accurately, thereby reducing review times for drug and medical device approvals. The FDA intends to improve its interactions with stakeholders, ensuring a more efficient response to public health needs. This move reflects a broader trend in the healthcare sector, where AI technologies are increasingly being adopted to optimize workflows and decision-making. The FDA’s commitment to integrating AI underscores its goal of modernizing regulations and improving overall safety and efficacy standards in healthcare.

Source link